Akebia Therapeutics, Inc. (AKBA) Social Stream



Akebia Therapeutics, Inc. (AKBA): $1.83

0.41 (-18.30%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

C

Add AKBA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#33 of 365

in industry

AKEBIA THERAPEUTICS INC (AKBA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering AKBA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-05 4 $8 $2.75 $5.937 $1.48 301.15%
2022-01-28 2 $10 $6 $8 $1.48 440.54%
2022-03-02 3 $10 $6 $8 $1.48 440.54%
2022-03-08 4 $10 $6 $8 $1.48 440.54%
2022-03-31 7 $2 $2 $2 $1.48 35.14%
2022-05-10 7 $2 $1 $1.75 $1.48 18.24%
2022-05-16 6 $2 $1.25 $1.75 $1.48 18.24%
2022-06-06 7 $2 $1 $1.562 $1.48 5.54%
2023-03-10 5 $2 $1.25 $1.75 $1.48 18.24%
2023-04-26 2 $2 $2 $2 $1.48 35.14%
2023-05-26 3 $2 $2 $2 $1.48 35.14%
2023-07-24 3 $4 $2 $3 $1.48 102.7%
2023-08-25 3 $4 $2 $3 $1.48 102.7%
2023-11-09 3 $4 $3.75 $3.875 $1.48 161.82%
2023-11-17 3 $5 $4 $4.5 $1.48 204.05%
2023-11-29 4 $5 $4 $4.333 $1.48 192.77%

The Trend in the Analyst Price Target


AKBA's average price target has moved down $12.79 over the prior 43 months.

AKBA reports an average of 188.93% for its upside potential over the past 38 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-10 2 2 1.25 1.625 0.799 103.38%
2023-08-25 3 4 2.00 3.000 1.150 160.87%
2023-11-09 3 4 3.75 3.875 0.910 325.82%
2023-11-17 3 5 4.00 4.500 1.000 350%
2023-11-29 4 5 4.00 4.333 1.000 333.3%

AKBA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


AKBA's average broker recommendation rating improved by 1.33 over the prior 15 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, AKEBIA THERAPEUTICS INC's average analyst price target is higher than 45.14% of them.
  • In terms of how AKEBIA THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 257.53% of that group.
  • In the context of Pharmaceutical Products stocks, AKEBIA THERAPEUTICS INC's variance in analysts' estimates is lower than -337.21% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, AKEBIA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 810.26% of them.

In the Pharmaceutical Products industry, EGRX, CPRX, and LXRX are the three stocks most similar to AKEBIA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is AKBA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!